Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-05-25 @ 9:03 PM
Study NCT ID:
NCT06586957
Status:
RECRUITING
Last Update Posted:
2025-10-22
First Post:
2024-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Sponsor:
NiKang Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
| None | Advanced Solid Tumor | View |
| None | Solid Tumor, Adult | View |
| None | Metastatic Tumor | View |
| None | Ovarian Cancer | View |
| None | Ovarian Neoplasms | View |
| None | Ovarian Carcinoma | View |
| None | Metastatic Ovarian Carcinoma | View |
| None | Endometrial Neoplasms | View |
| None | Endometrial Diseases | View |
| None | Metastatic Endometrial Cancer | View |
| None | Triple Negative Breast Cancer | View |
| None | Metastatic Endometrial Carcinoma | View |
| None | Advanced Endometrial Carcinoma | View |
| None | Advanced Ovarian Carcinoma | View |
| None | Gastric Cancer | View |
| None | Advanced Gastric Carcinoma | View |
| None | Metastatic Gastric Cancer | View |
| None | Metastatic Gastric Carcinoma | View |
| None | Small Cell Lung Cancer | View |
| None | Small Cell Lung Carcinoma | View |
| None | Triple Negative Breast Neoplasms | View |
| None | Platinum-resistant Ovarian Cancer | View |
| None | Platinum-refractory Ovarian Carcinoma | View |
| None | CCNE1 Amplification | View |
| None | Hormone Receptor Negative Breast Carcinoma | View |
| None | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | View |
| None | Progesterone-receptor-positive Breast Cancer | View |